Changhong Ke
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Targeted co-delivery of curcumin and TRAIL via engineered extracellular vesicles: a synergistic therapy against resistant cancers.
Journal: Drug delivery and translational research
Published: March 23, 2026
Selective CDK9 knockdown sensitizes TRAIL response by suppression of antiapoptotic factors and NF-kappaB pathway.
Journal: Apoptosis : an international journal on programmed cell death
Published: April 01, 2023
Extracellular vesicle-mediated co-delivery of TRAIL and dinaciclib for targeted therapy of resistant tumors.
Journal: Biomaterials science
Published: February 16, 2022
Sensitizing TRAIL response via differential modulation of anti- and pro-apoptotic factors by AZD5582 combined with ER nanosomal TRAIL in neuroblastoma.
Journal: Acta histochemica
Published: November 05, 2021
EV-T synergizes with AZD5582 to overcome TRAIL resistance through concomitant suppression of cFLIP, MCL-1, and IAPs in hepatocarcinoma.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: October 12, 2021
Mitochondria-Targeted Triphenylphosphonium Conjugated C-3 Modified Betulin: Synthesis, Antitumor Properties and Mechanism of Action.
Journal: ChemMedChem
Published: October 12, 2021
TRAIL-Armed ER Nanosomes Induce Drastically Enhanced Apoptosis in Resistant Tumor in Combination with the Antagonist of IAPs (AZD5582).
Journal: Advanced healthcare materials
Published: January 07, 2021
Migration mechanism of mesenchymal stem cells studied by QD/NSOM.
Journal: Biochimica et biophysica acta
Published: September 09, 2014
Showing 1-10 of 10
Last Updated: 09/26/2026